Category: Moderna

Pfizer and Moderna Will Raise the Price of Their Vaccines After Adaptation to New Variants

By Entrepreneur Staff Pharmaceutical companies Pfizer and Moderna will increase the price of their respective vaccines after adapting to new variants of the Covid-19 virus. This was confirmed by Clément Beaune, French Secretary of State for European Affairs to the Financial Times, according to El Economista. What will the new prices be? According to the British newspaper,…


Pfizer and Moderna Raise Prices for COVID-19 Vaccines in EU: Financial Times

Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price for the Pfizer shot was €19.50 ($23.15) against €15.50 ($18.40) previously, the newspaper said, citing portions of the contracts seen. The price of a Moderna vaccine was $25.50…


FDA Asks Pfizer and Moderna to Include More Children in COVID-19 Vaccine Trials: Reports

The Food and Drug Administration (FDA) has asked Pfizer and Moderna to expand their COVID-19 vaccine trials for 5 to 11-year-olds in an effort to determine whether a rare side effect in the form of heart inflammation is more common among younger groups, according to reports. The FDA has asked the two pharmaceutical companies to…


EU Regulator Endorses Use of Moderna’s COVID-19 Vaccine in Teens

Europe’s medicines regulator on Friday recommended approving the use of Moderna’s COVID-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the bloc. The use of the vaccine, branded Spikevax, will be the same in adolescents as in people above 18 years, the…


Pfizer Shots Could Be Available to Australians Under-40 in September

Pfizer vaccines could be available to Australians under 40 as early as September or October, the head of the COVID-19 vaccine task force said on Tuesday. Lieutenant-General John Frewen told reporters that currently, there was a limited amount of imported Pfizer vaccines and an abundance of locally-made AstraZeneca. Therefore the current age group priorities would…


Moderna’s COVID-19 Vaccine Shows Promise Against Multiple Variants, Including Delta: Study

Moderna said Tuesday that a new lab study shows its COVID-19 vaccine should provide protection against emerging mutations of the CCP (Chinese Communist Party) virus, including the highly contagious Delta variant that has health officials on edge. In vitro neutralization studies of blood obtained from eight people one week after they were vaccinated with their…


Pfizer and Moderna COVID Vaccines May Provide ‘Persistent’ Protection: Study

Researchers have said in a new study that both Moderna’s COVID-19 vaccine and that produced by the Pfizer-BioNTech alliance may provide lasting protection against the CCP (Chinese Communist Party) virus. The peer-reviewed study, published on June 28 in Nature, found that the messenger RNA (mRNA) vaccines made by Moderna and the Pfizer-BioNTech team induced a…


Moderna Applies for Full ‘Biologics License’ Approval of Its COVID-19 Vaccine

Moderna on Tuesday applied for a so-called “biologics license” for its COVID-19 vaccine, a step up from its current emergency use authorization that would open the shot to interstate commerce and allow the drugmaker to market it directly to consumers. The company’s mRNA vaccine was approved for emergency use by the Food and Drug Administration…


Moderna Says Its COVID-19 Vaccine Is 100 Percent Effective in Adolescents

Moderna on Tuesday said its COVID-19 vaccine was shown to be 100 percent effective in children between the ages of 12 and 17. No cases of COVID-19 were observed in clinical trial participants who received two doses of Moderna’s shot, the Massachusetts-based biotechnology company said in a press release. Moderna announced the results because it…


Australia Secures 25 Million Moderna Vaccines

The Australian government has secured 25 million doses of the two-dose Moderna vaccine and is also in talks with the company to establish an mRNA manufacturing facility in the country. “Moderna is, on the advice that we have, the most advanced of the vaccine products with relation to the capacity to adapt to booster and…